.png){kind=icon}
.png){kind=icon}
Back
U
University Hospital Schleswig-Holstein - Campus Kiel
Scholars1
Papers1
Citations0
Related Papers (1)
Publication Date
.png){kind=icon}
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment.png)
BMC Cancer.png)
OAAI
BMC CancerIF3.4
OAAI.png){kind=icon}
Share.png){kind=icon}
Save